10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,018,403 | +1469.3% | 197,321 | +924.1% | 0.02% | +1000.0% |
| Q4 2022 | $702,126 | -51.4% | 19,268 | +98.6% | 0.00% | -33.3% |
| Q4 2021 | $1,446,000 | -96.7% | 9,704 | -96.7% | 0.00% | -98.3% |
| Q3 2021 | $43,288,000 | +18.9% | 297,343 | +15.6% | 0.18% | -8.6% |
| Q4 2020 | $36,412,000 | +218.0% | 257,149 | +180.0% | 0.20% | +169.9% |
| Q3 2020 | $11,449,000 | +578.3% | 91,824 | +385.8% | 0.07% | +508.3% |
| Q2 2020 | $1,688,000 | -53.9% | 18,900 | -67.8% | 0.01% | -67.6% |
| Q1 2020 | $3,662,000 | – | 58,759 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |